2.3. The ERK1/2 Phosphorylation Is a Prognostic Biomarker for the Survival of Oropharyngeal Squamous Cell Carcinoma (OPSCC) Patients Dependent on Human Papillomavirus (HPV) Status. The gene discussed is MAPK3; the disease is oropharynx squamous cell carcinoma.